Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Short-course Radiotherapy Plus Chemotherapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 16 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT05563012
What this trial is testing

Short-course Radiotherapy Combined With Neoadjuvant Chemotherapy and PD-1 Inhibitor in the Treatment of Locally Advanced Gastric Adenocarcinoma

Who this might be right for
Disorder in Complete Remission in Response to Treatment
Renmin Hospital of Wuhan University 29
Testing effectiveness (Phase 2)UnknownNCT03484221
What this trial is testing

Totally Neoadjuvant FOLFOXIRI + Short-course Radiation + XELOX in Patients With Locally Advanced Rectal Cancer

Who this might be right for
Rectal NeoplasmsDrug TherapyRadiation
China Medical University, China 30
Testing effectiveness (Phase 2)UnknownNCT05359406
What this trial is testing

A Combination Therapy Including Anti-PD-1 Immunotherapy in Rectal Cancer With Refractory Distal Metastasis

Who this might be right for
Advanced Rectal CancerDistal Metastasis
LI XIN-XIANG 51
Not applicableUnknownNCT03676517
What this trial is testing

Evaluation of Efficacy, Quality of Life and Cost Effectiveness of Short-course Radiotherapy Followed by Capecitabine Plus Oxaliplatin chemotheRapy and TME for High-risk Rectal Cancer (ESCORT Trial)

Who this might be right for
Locally Advanced Rectal Cancer
Yonsei University 31
Large-scale testing (Phase 3)Looking for participantsNCT07549399
What this trial is testing

SCRT + Chemo Targeted Immuno-neoadjuvant Therapy for High-risk pMMR/MSS RC

Who this might be right for
Rectal AdenocarcinomaHigh-Risk CancerMSS
Sixth Affiliated Hospital, Sun Yat-sen University 204
Testing effectiveness (Phase 2)UnknownNCT04231552
What this trial is testing

Preoperative Short Course Radiotherapy With Chemotherapy and Camerelizumab in Locally Advanced Rectal Cancer

Who this might be right for
Rectal CancerRadiotherapyImmunotherapy
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 30
Not applicableNot Yet RecruitingNCT07674342
What this trial is testing

Neoadjuvant PD-1 Inhibitor Plus SOX Chemotherapy With or Without Short-Course Radiotherapy for Locally Advanced Upper Gastric or GEJ Adenocarcinoma

Who this might be right for
Locally Advanced Proximal Gastric or Gastroesophageal Junction Adenocarcinoma
Tongji Hospital 146
Testing effectiveness (Phase 2)Looking for participantsNCT07347951
What this trial is testing

A Single-center, Phase II Study on Efficacy & Safety of SCRT+CAPOX+Serplulimab+Bevacizumab for MSS Rectal Cancer

Who this might be right for
Locally Advanced Rectal Cancer (LARC)
First Affiliated Hospital of Wenzhou Medical University 30
Large-scale testing (Phase 3)Looking for participantsNCT06958432
What this trial is testing

Node-Sparing Short-Course Radiotherapy Sequential Chemotherapy and PD-1 Inhibitor for Mid/Low pMMR/MSS Rectal Cancer (MODIFI-RC-II)

Who this might be right for
Rectal CancerNeoadjuvant TherapiesImmune Checkpoint Therapy+1 more
Sixth Affiliated Hospital, Sun Yat-sen University 430
Testing effectiveness (Phase 2)UnknownNCT02510378
What this trial is testing

Short Course Radiotherapy Combined With Chemotherapy in Stage IV Rectal Cancer With Resectable Liver Metastases

Who this might be right for
Stage IV Rectal Cancer, Liver Metastasis, Resectable
Chinese Academy of Medical Sciences 47
Testing effectiveness (Phase 2)Active Not RecruitingNCT05253846
What this trial is testing

Short-course Radiotherapy Followed by Consolidation Chemotherapy. 2021-001206-29

Who this might be right for
Locally Advanced Rectal Cancer
Gruppo Oncologico del Nord-Ovest 63
Testing effectiveness (Phase 2)Looking for participantsNCT06718543
What this trial is testing

Neoadjuvant Short-Course Radiotherapy With or Without Chemotherapy and AK112 in Locally Advanced Rectal Cancer

Who this might be right for
Rectal Cancer
fan li 100
Large-scale testing (Phase 3)UnknownNCT04370418
What this trial is testing

Neo-adjuvant Short Course Chemo-radiation Therapy in Locally Advanced Rectal Cancer Patients

Who this might be right for
Neo-adjuvant Short Course Chemo-radiotherapy in Locally Advanced Cancer Rectum
Assiut University 8
Testing effectiveness (Phase 2)UnknownNCT04674696
What this trial is testing

Short-course Radiotherapy With Induction and Consolidation Chemotherapy in Patients With Locally Advanced Rectal Cancer

Who this might be right for
Rectal CancerTotal Neoadjuvant Treatment
Instituto Nacional de Cancer, Brazil 54
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07543848
What this trial is testing

A Prospective, Multicenter, Single-Arm Phase II Exploratory Study of Serplulimab Combined With Oncolytic Virus H101, Short-Course Radiotherapy, and XELOX Chemotherapy as Total Neoadjuvant Treatment for Locally Advanced (cT1-3N0M0) Rectal Cancer

Who this might be right for
Rectal NeoplasmsRectal Adenocarcinoma
Chongqing University Cancer Hospital 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT07663071
What this trial is testing

Short-course Radiotherapy Combined With Retlirafusp Alfa and CAPOX Chemotherapy as Neoadjuvant Therapy for Locally Advanced Rectal Cancer: A Prospective, Single-arm, Phase II Clinical Study

Who this might be right for
Rectal Cancer Patients
Harbin Medical University 44